Stuart K. Williams
Directeur Technique/Scientifique/R&D chez Koligo Therapeutics, Inc.
Profil
Stuart K.
Williams is currently an Executive Director at Koligo Therapeutics Ltd., a Professor at the University of Louisville, and the Chief Technology Officer at Koligo Therapeutics, Inc. Previously, he worked as the Director-Research at Sidney Kimmel Medical College and as the Chief Scientific Officer at TGI Holdings, Inc. Dr. Williams holds a doctorate degree from the University of Delaware.
Postes actifs de Stuart K. Williams
| Sociétés | Poste | Début |
|---|---|---|
Koligo Therapeutics Ltd.
 Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | Directeur/Membre du Conseil | - |
Koligo Therapeutics, Inc.
 Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | Directeur Technique/Scientifique/R&D | - |
| University of Louisville | Corporate Officer/Principal | - |
Anciens postes connus de Stuart K. Williams
| Sociétés | Poste | Fin |
|---|---|---|
TGI Holdings, Inc. /Hawaii/
 TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Directeur Technique/Scientifique/R&D | - |
| Sidney Kimmel Medical College | Corporate Officer/Principal | - |
Formation de Stuart K. Williams
| University of Delaware | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Koligo Therapeutics Ltd.
Koligo Therapeutics Ltd. Medical SpecialtiesHealth Technology Koligo Therapeutics Ltd. engages in development and commercialization of cell therapy, three dimensional bio-printed tissue and other regenerative medicine products. The company was founded on June 27, 2018 and is headquartered in Sydney, Australia. | Health Technology |
Koligo Therapeutics, Inc.
Koligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Koligo Therapeutics, Inc. develops, manufactures and commercializes transformative cell therapies for the treatment of pancreatic diseases. The company is headquartered in New Albany, IN. | Health Technology |
TGI Holdings, Inc. /Hawaii/
TGI Holdings, Inc. /Hawaii/ Medical SpecialtiesHealth Technology TGI Holdings, Inc. develops tissue engineering and cell therapy solutions. The company was founded by Anton C. Krucky, Thomas F. Cannon, and William P. Wiesmann in 2001 and is headquartered in Honolulu, HI. | Health Technology |
